HomeNews

News

FDA Approves Avastin Biosimilar Jobevne Throughout A number of Most cancers Varieties

The FDA has authorized Jobevne, a biosimilar to Avastin, for IV use in various most cancers varieties.The U.S. Meals and Drug Administration has...

Managing Most cancers Calls for Flexibility and a Strategic Mindset

After surviving prostate most cancers, Andy Winnegar obtained a analysis of persistent lymphocytic leukemia (CLL) in 2021. Make amends for Andy's blogs right...

FDA Grants Full Approval to Vitrakvi For NTRK-Constructive Strong Tumors

The U.S. Meals and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the remedy of grownup and pediatric sufferers with...

Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award

The 2025 Extraordinary Healer® Award was introduced throughout the fiftieth Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impression.CURE Media...

First Affected person Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors

The examine will consider the protection and efficacy of CT-95 in mesothelin-expressing tumors.The primary affected person has been dosed in a section 1...

Hot Topics